Medication info
Hanin Memantine Od Tablet 10 mg (Memantine Hydrochloride)

Hanin Memantine Od Tablet 10 mg (Memantine Hydrochloride)

Prescription medicationOrally disintegrating TabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Hanin Pharmaceutical Co., Ltd.
Appearance
White round orally disintegrating tablet
Packaging
Domestic - 90 tablets/box [10 tablets/PTP×9], Export - 30 tablets/box [10 tablets/PTP×3]
Approval status
Active

MFDS item code 201706584 · Approved 2017.08.14 · Insurance code 657203190

Summary

Main use
Treatment of moderate to severe Alzheimer’s disease
Who takes it
Adults
Adult dose
Administer this medicine orally once daily at the same time each day. If necessary, it may be administered twice daily. It may be taken with or without food. This medicine is an orally disintegrating tablet. Place it on the tongue and allow it to dissolve; take it without water. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Day 1~7) Administer 5mg once daily for 7 days. Week 2 (Day 8~14) Administer 10mg once daily for 7 days. Week 3 (Day 15~21) Administer 15mg once daily for 7 days. Starting in Week 4 Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults: Based on clinical data, the recommended dose for older patients aged 65 years or older is 20mg once daily. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If the dose is well tolerated after at least 7 days of treatment, it may be increased to 20mg once daily according to the standard dose-escalation regimen. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine to them.

Ingredients

Manufacturer
Hanin Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer’s disease

  • Moderate Alzheimer's disease
  • severe Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease. It helps improve memory and cognitive function decline due to brain function impairment, thereby facilitating the patient's daily life. It also helps slow the progression of symptoms and improve the patient's quality of life.

How to take

Adult dose

Administer this medicine orally once daily at the same time each day. If necessary, it may be administered twice daily. It may be taken with or without food. This medicine is an orally disintegrating tablet. Place it on the tongue and allow it to dissolve; take it without water. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Day 1~7) Administer 5mg once daily for 7 days. Week 2 (Day 8~14) Administer 10mg once daily for 7 days. Week 3 (Day 15~21) Administer 15mg once daily for 7 days. Starting in Week 4 Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults: Based on clinical data, the recommended dose for older patients aged 65 years or older is 20mg once daily. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If the dose is well tolerated after at least 7 days of treatment, it may be increased to 20mg once daily according to the standard dose-escalation regimen. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine to them.

Precautions

This medication contains the artificial sweetener aspartame, which is metabolized in the body, so patients with the genetic disorder phenylketonuria should not take it. Care should be taken not to exceed the maximum daily allowance for aspartame, and it is safe for adults to consume below 2.4 grams per day. Patients who are allergic to any components of this medication or who have severe liver and kidney dysfunction should not take this medication. Patients with epilepsy or those who have experienced seizures should use this medication with caution, and it should be avoided when taken with certain NMDA antagonists due to increased risk of side effects. Patients with changes in urine acidity or uncontrolled cardiac disease and hypertension also need to be cautious. While taking this medication, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur, and if symptoms are severe, a doctor should be consulted. There is potential for interaction with other medications, especially when taken with NMDA antagonists, antipsychotic drugs, muscle relaxants, and anticoagulants, so follow the instructions of a professional. Women who are pregnant or might become pregnant should consult a doctor before taking this medication, as it may affect the fetus. Nursing women should consider discontinuing breastfeeding, as this medication may pass into breast milk. Safety and efficacy in children and adolescents under 18 years have not been established, so use should be avoided. In case of overdose, central nervous system and gastrointestinal symptoms may occur, and prompt medical attention should be sought. This medication may affect the patient's reaction times, so caution is required when driving or operating machinery. Finally, store this medication out of reach of children and do not transfer it to another container as this is important for maintaining the quality of the medication.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucinations
  • psychotic reactions
Show 23 more
  • balance disorders
  • gait abnormalities
  • seizures
  • heart failure
  • venous thrombosis/thromboembolism
  • dyspnea
  • vomiting
  • pancreatitis
  • elevation of liver function tests
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • anxiety
  • aggression
  • stupor
  • unconsciousness
  • restlessness
  • psychosis
  • visual disturbances
  • coma
  • diplopia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage ensures the safe retention of the medication's efficacy.

Appearance and packaging

Appearance

White round orally disintegrating tablet

Package unit

Domestic - 90 tablets/box [10 tablets/PTP×9], Export - 30 tablets/box [10 tablets/PTP×3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.